These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Eison AS; Temple DL Am J Med; 1986 Mar; 80(3B):1-9. PubMed ID: 2870639 [TBL] [Abstract][Full Text] [Related]
5. Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy. Goldberg HL Pharmacotherapy; 1984; 4(6):315-24. PubMed ID: 6151170 [TBL] [Abstract][Full Text] [Related]
6. Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Goa KL; Ward A Drugs; 1986 Aug; 32(2):114-29. PubMed ID: 2874976 [TBL] [Abstract][Full Text] [Related]
7. Buspirone: chemical profile of a new class of anxioselective agents. Temple DL; Yevich JP; New JS J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):4-10. PubMed ID: 6185470 [TBL] [Abstract][Full Text] [Related]
8. Preclinical pharmacology of buspirone hydrochloride. Skolnick P; Paul SM; Weissman BA Pharmacotherapy; 1984; 4(6):308-14. PubMed ID: 6151169 [TBL] [Abstract][Full Text] [Related]
10. Buspirone: a new type of anxiolytic. Dommisse CS; DeVane CL Drug Intell Clin Pharm; 1985 Sep; 19(9):624-8. PubMed ID: 2864225 [TBL] [Abstract][Full Text] [Related]
11. Serotonergic mechanisms in the behavioral effects of buspirone and gepirone. Eison AS; Eison MS; Stanley M; Riblet LA Pharmacol Biochem Behav; 1986 Mar; 24(3):701-7. PubMed ID: 2871564 [TBL] [Abstract][Full Text] [Related]
12. Notes on buspirone's mechanisms of action. Garattini S; Caccia S; Mennini T J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of SM-3997: a new anxioselective anxiolytic candidate. Shimizu H; Hirose A; Tatsuno T; Nakamura M; Katsube J Jpn J Pharmacol; 1987 Dec; 45(4):493-500. PubMed ID: 2895201 [TBL] [Abstract][Full Text] [Related]
14. Buspirone and related compounds as alternative anxiolytics. Taylor DP; Moon SL Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210 [TBL] [Abstract][Full Text] [Related]
15. Neuropharmacological profile of buspirone: a non-benzodiazepine anxiolytic with specific mid-brain modulating properties. Leonard BE Br J Clin Pract Suppl; 1985 May; 38():74-82. PubMed ID: 2862907 [No Abstract] [Full Text] [Related]
16. Pharmacology and neurochemistry of buspirone. Riblet LA; Taylor DP; Eison MS; Stanton HC J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):11-8. PubMed ID: 6130068 [TBL] [Abstract][Full Text] [Related]
17. Buspirone: an anxioselective alternative for the management of anxiety disorders. Riblet LA; Eison AS; Eison MS; Newton RE; Taylor DP; Temple DL Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):663-8. PubMed ID: 6364236 [TBL] [Abstract][Full Text] [Related]
18. Buspirone: chemistry, pharmacology, and behavior. Skolnick P; Paul SM J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):40-4. PubMed ID: 6130072 [TBL] [Abstract][Full Text] [Related]
19. Alcohol and drug interactions with antianxiety medications. Schuckit MA Am J Med; 1987 May; 82(5A):27-33. PubMed ID: 2884873 [TBL] [Abstract][Full Text] [Related]